Actinogen Medical Limited

ASX (AUD): Actinogen Medical Limited (ACW)

Last Price

0.026

Today's Change

+0.002 (8.33%)

Day's Change

0.024 - 0.026

Trading Volume

6,340,377

Profile
ACW

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D. Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.

Full Time Employees:  0 0

IPO Date:  2007-10-16 2007-10-16

CIK: 

ISIN:  AU000000ACW3 AU000000ACW3

CUSIP:  Q0094Y104 Q0094Y104

Beta:  1.23 1.23

Last Dividend:  0.00 0.00

Dcf Diff:  0.02 0.02

Dcf:  0.00 0.00

Description

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Address

109 Pitt Street,
Sydney, NSW 2000, AU

61 2 8964 7401

http://www.actinogen.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment